Kalon Stake Gives Fujifilm Ebola Vaccine Capacity
This article was originally published in PharmAsia News
A Fujifilm Holdings Corp. subsidiary is to acquire a major stake in a private U.S. contract vaccine manufacturing firm, expanding the Japanese group's interests in the growing biologics production field and providing it with new capabilities for Ebola vaccines if needed.
You may also be interested in...
Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.
US pharma giant joins Singapore alliance aiming to encourage regional startups and innovation, in multiple tech-related areas including digital health, through the provision of expertise and support.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.